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In the present study, the presence of the phloroglucinol derivative hyperforin, the naphthodianthrones hypericin and pseudo-
hypericin, the phenylpropane chlorogenic acid and the ﬂavonoids rutin, hyperoside, kaempferol, isoquercetine, quercitrine, and
quercetine was investigated in Hypericum leptophyllum Hochst., an endemic Turkish species for the ﬁrst time. The aerial parts
representing a total of 30 individuals were collected at full ﬂowering and dissected into ﬂoral, leaf, and stem tissues. After being
dried at room temperature, the plant materials were assayed for secondary metabolite concentrations by HPLC. Aerial plant parts
accumulated chlorogenic acid, hyperoside, isoquercetine, quercitrine, and quercetine, but they did not accumulate hyperforin,
hypericin, pseudohypericin, rutin, and kaempferol. Accumulation levels of the detected compounds varied with plant tissues.
Such kind of data could be useful for elucidation of the chemotaxonomical signiﬁcance of the corresponding compounds and
phytochemical evaluation of this endemic species.
1.Introduction
The genus Hypericum L. from the family of Hypericaceae
comprises more than 450 species divided in 36 sections with
worldwide distribution in warm temperate, subtropical, and
mountainous tropical regions [1]. Many herbs from genus
Hypericum are pharmacologically important, particularly
Hypericum perforatum L. which has been studied widely for
itssecondarymetabolitescompositionandbiologicalactivity
[2, 3]. Turkey is an important centre of Hypericum species
origin and distribution where presently there are 89 regis-
tered species of which 43 are endemic [4]. All species of
Hypericum from Turkish ﬂora have been traditionally used
assedatives,antiseptics, andantispasmodics infolkmedicine
under the names: kantaron, peygamber c ¸ic ¸e˘ gi, kilic ¸otu,kan-
otu, kuzukıran, and binbirdelik otu [5]. Hypericum lepto-
phyllum Hochst. which grows in dry stony or rocky calcare-
ous zones of central Anatolia is one of the endemic species of
Turkishﬂora.Plantstemis20–60cminlength,erect,orpros-
trate, branching from the base. Leaves are 5–35mm in size,
oblong, or linear to elliptic. Yellow ﬂowers are numerous
without black dots, like the leaves. Capsules are 5–10mm in
diameter with dorsal vital and lateral vesicles [4].
The major phytomedicinal compounds of Hypericum
plants are thought to be phloroglucinol derivatives hyper-
forin and adhyperforin, naphthodianthrones hypericin and
pseudohypericin,andthephenolics,asﬂavonoidhyperoside,
rutin, quercitrin, quercetin and biapigenin, and phenylpro-
pane caﬀeic and chlorogenic acids, which possess a wide
array of biological properties [6]. Results from recent studies
haveindicatedhyperforinasthemaincompoundresponsible
for antidepressant eﬀect of Hypericum extract, and it also
exhibits anti-inﬂammatory and antiangiogenic eﬀects [7].
The naturally occurring red pigments hypericin and pseudo-
hypericin have been reported to exhibit important biological
activities, namely, photodynamic, antiviral, antiretroviral,
antibacterial, antipsoriatic, antidepressant, and antitumoral
activities [8]. Flavonoids are a group of bioactive phenolics
present in Hypericum plants. Results from clinical studies
indicated the possible role of ﬂavonoids in prevention of2 The Scientiﬁc World Journal
cardiovascular diseases and some kinds of cancer [9]. Al-
though hyperforin and hypericins have been reported to
mainly contribute to the pharmacological eﬀects of Hyper-
icum extracts, ﬂavonoids have also made an important con-
tribution to the antidepressant activity [10]. In this sense,
many species of Hypericum from diﬀerent localities of the
w o r l da sw e l la sT u r k i s hﬂ o r ah a v eb e e ni n v e s t i g a t e df o rt h e
presence of the chemicals especially over the last decade [11–
17]. However, to author’s knowledge, there is no reported
data on the chemistry of H. leptophyllum. The aim of the
present study was to expand the knowledge on composition
of ﬂowering aerial parts of this endemic species in order to
reveal the potential possibilities of using ones as pharmaceu-
tical material.
2.MaterialandMethods
2.1. Plant Material. T h ea e r i a lp a r t so fH. leptophyllumre-
presentingatotalof30individualswerecollectedatfullﬂow-
ering in June of 2010 from Yozgat, Turkey (39◦ 50  N Lat.,
34◦ 48  E Long., and 1420m elevation). The plant material
was dissected into ﬂoral, leaf, and stems tissues, dried at
room temperature (20 ± 2◦C). The species was identiﬁed by
Professor Dr. Hasan Ozcelik, Faculty of Science and Art,
Department of Biology, University of Suleyman Demirel,
Isparta, Turkey. Voucher specimen was deposited in the her-
barium of Vocational High School of Bafra (BMYO no. 127),
Ondokuz Mayis University.
2.2. Preparation of Plant Extracts. Air-dried plant material
was mechanically ground with a laboratory mill to obtain a
homogenous drug powder. Samples of about 0.5g (weighed
with 0.0001g precision) were extracted in 50mL of 100%
methanolbyultrasonicationat40◦Cfor30min.inaSonorex
SupermodelRK225Hultrasonicbath.Thepreparedextracts
were ﬁltered through a membrane ﬁlter with pore size of
0.22µm(CarlRothGmbH,Karlsruhe,Germany)andkeptin
a refrigerator until analysis no longer than 3 hours. The
extracts for naphthodianthrones analysis after ultrasonica-
tion were exposed to light for 30min. due to the photocon-
version of protohypericin into hypericin and protopseudo-
hypericin into pseudohypericin.
2.3. HPLC Analysis . A Shimadzu Prominence LC-20A
(Shimadzu Europa GmbH, Duisburg, Germany) chromato-
graphic system equipped with two LC-20AD model pumps,
a SIL-20AC auto-injector, a thermostat CTO-20AC, and a
SPD-M20A detector was used for HPLC analysis. Separation
of all compounds was carried out using an YMC Pack Pro-
C18 (YMC Europe GmbH, Dinslaken, Germany) column
(150mm × 4mm i.d.; 3µm particle sizes) with 10mm guard
precolumn. The mobile phase consists of solvent A (water
containing 0.1% triﬂuoroacetic acid (TFA)) and solvent B
(acetonitrile containing 0.1% TFA). The following binary
gradient elution program was used: 0-1min (B 5→5%),
1–14min (B 5→20%), 14–20min (B 20→80%), 20–30min
(B 80→100%), 30–39min (B 100→100%), 39–39.5min
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Figure 1: HPLC chromatogram of Hypericum leptophyllum meth-
anolic extract detected by UV at 353nm wave length. Peak iden-
tiﬁed: 1—chlorogenic acid (retation time (tR)—9.61min.), 2—hy-
peroside (tR—16.13min.), 3—isoquercetine (tR—16.49min.), 4—
quercetrine (tR—17.45min.), 6–quercetine–(tR—18.62min.).
was delivered with a ﬂow rate of 1.0mL min−1;v o l u m eo f
extract injected was 10µL. Detection was performed at 210–
790nm wave length range with a constant column tempe-
rature at 40◦C. The eluted compounds were identiﬁed on the
basis of their retention time by comparison with retention
time of reference standards and also conﬁrmed with UV
spectra of reference standards in the wavelength range from
210 to 790nm.
The hypericin and pseudohypericin elution program was
isocratic. The mobile phase consists of acetonitrile contain-
ing 0.1% TFA. Flow rate of mobile phase was 1.1mL·min−1.
Ten micro liters of extracts were injected. Detection was
recorded at 210–790nm wave length range with a constant
column temperature at 40◦C. The quantiﬁcation of detected
compounds was achieved by using external standard meth-
od at the maximal absorption on the UV spectra of corre-
sponding compounds: chlorogenic acid—325nm, rutin—
353nm, hyperoside—353nm, isoquercetrine—353, kaemp-
ferol—346nm, quercetrine—347nm, quercetine–368nm,
hyperforin—270nm, and hypericin and pseudohypericin—
580nm wavelength. A six-point calibration curves were ob-
tained with pure standards dissolved in MeOH in the con-
centration range of 0.2–110µg/mL. All calibration cures
showed good linear regression (r2 > 0.999) within the test
range. Typical HPLC chromatograms of Hypericum lepto-
phyllum ﬂower extract are shown in Figure 1. All solvents
and standards of reference substances were of HPLC grade
and purchased from Roth Chemical Company (Karlsruhe,
Germany).
3. Results and Discussion
In the present study, we observed that the aerial plant parts
accumulated the phenylpropane chlorogenic acid and the se-
veral ﬂavonoids, namely, hyperoside, isoquercetine, quer-
citrine, and quercetine. We did not detect phloroglucinol
derivative hyperforin and naphthodianthrones as hypericin
andpseudohypericin.Theaccumulationofhypericinsispro-
duced in the dark glands, and the occurrence of dark glands
in an organ is regarded as a reliable indicator of the presenceThe Scientiﬁc World Journal 3
Table 1: Secondary metabolites content (mg/g DW) in stem, leaf, and ﬂower of Hypericum leptophyllum.
Plant parts Chlorogenic acid Hyperoside Isoquercetine Quercitrine Quercetine
Flower 17.47 2.69 16.98 0.10 2.39
Leaf 24.55 3.74 10.58 0.09 2.19
Stem 14.01 1.84 8.42 0.00 1.61
Table 2: Comparison of the content (mg/g DW) of chlorogenic acid, hyperoside, isoquercetine, quercitrine, and quercetine in Hypericum
leptophyllum and Hypericum perforatum (compiled from referred sources).
Compounds H. leptophyllum H. perforatum References
Chlorogenic acid 14.01–24.55 1.11–2.19 Maggi et al. [13]
Hyperoside 1.84–3.74 2.07–7.69 Maggi et al. [13]
Isoquercetine 8.42–16.98 — No previous report
Quercitrine 0.00–0.10 0.05–4.77 Radusiene et al. [18]; M´ artonﬁ et al. [15]
Quercetine 1.61–2.39 0.05–24.12 Radusiene et al. [18]; M´ artonﬁ et al. [15]
of hypericins in a given species [1]. Morphologically we ob-
served no dark glands on the aerial parts of H. leptophyllum
plants, and this is a possible reason why plant tissues do not
accumulate hypericins.
Accumulationlevelsofthedetectedphenoliccompounds
varied with plant tissues. Isoquercetine, quercitrine, and
quercetine were accumulated mainly in ﬂowers, while leaves
were found to be superior over ﬂowers in terms of chloro-
genic acid and hyperoside accumulations (Table 1). The dif-
ferences in chemical composition between leaves and ﬂowers
found in the present study for the H. leptophyllum largely
correspondtothosedescribedforH.perforatum,whoseﬂow-
ers accumulated larger amounts of quercetin and quercitrin
and whose leaves had the highest level of hyperoside [19].
In other species of Hypericum, similarly, quercitrine and
quercetine were accumulated mainly in ﬂoral parts while
leaves produced higher amounts of chlorogenic acid and
hyperoside in H. origanifolium [20], H. perfoliatum [21], and
H. maculatum [18].
Results from the present study indicate that H. lepto-
phyllum accumulates lower concentrations of quercetine and
quercitrine, comparable concentration of hyperoside, and
higher concentration of chlorogenic acid when compared to
H. perforatum, a well-known and commercial source of the
compounds examined (Table 2).
4. Conclusions
In conclusion, there is an increasing interest in recent years
for using medicinal and aromatic plants as natural sources in
pharmaceutical, food, biotechnology, agricultural, and cos-
metic industries all over the world. Thus, eﬀorts have been
made to discover new sources of potential biological active
secondary metabolites. In this sense, the present results en-
courage further studies on documenting potential pharma-
cological activity of H. leptophyllum. Here, the presence of
bioactive compounds examined in this endemic plant was
reported by us for the ﬁrst time. Such kind of data could also
be useful for elucidation of the chemotaxonomical signiﬁ-
cance of the corresponding compounds and phytochemical
evaluation of H. leptophyllum.
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